STOCK TITAN

NeuroBo Pharmaceuticals (NRBO) SEC Filings, Jun-Jul 2025

NRBO NASDAQ

Ticker history: NRBO became MTVA (MetaVia Inc.) on .

NeuroBo Pharmaceuticals Inc. filings, under the MetaVia Inc. registrant name after its name change, document a clinical-stage biotechnology issuer centered on cardiometabolic drug development. Recent Form 8-K disclosures include quarterly results and corporate updates, Regulation FD materials, corporate presentations, and press releases related to DA-1726 for obesity and DA-1241 for MASH.

The filing record also covers stockholder-meeting matters, including director elections, auditor ratification, executive-compensation advisory votes, reverse stock-split authorization proposals, Nasdaq share-issuance proposals, and common stock voting mechanics. These disclosures frame the company's governance, capital structure, clinical-development communications, and Exchange Act reporting obligations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many NeuroBo Pharmaceuticals (NRBO) SEC filings are available on StockTitan?

StockTitan tracks 18 SEC filings for NeuroBo Pharmaceuticals (NRBO). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for NeuroBo Pharmaceuticals (NRBO)?

The most recent SEC filing for NeuroBo Pharmaceuticals (NRBO) was filed on August 14, 2025.